This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Louis ED et al. (1998) How common is the most common adult movement disorder: estimates of the prevalence of essential tremor throughout the world. Mov Disord 13: 5–10
Benito-Leon J et al. (2003) Prevalence of essential tremor in three elderly populations of central Spain. Mov Disord 18: 389–394
Zesiewicz TA et al. (2005) Practice parameter: therapies for essential tremor: report of the quality standards subcommittee of the American Academy of Neurology. Neurology 64: 2008–2020
Connor GS (2002) A double-blind, placebo-controlled trial of topiramate treatment for essential tremor. Neurology 59: 132–134
Gironell A et al. (1999) A randomized placebo-controlled comparative trial of gabapentin and propranolol in essential tremor. Arch Neurol 56: 475–480
Acknowledgements
The synopsis was written by Martina Habeck, Associate Editor, Nature Clinical Practice.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Bhatia, K., Schneider, S. Is the anticonvulsant topiramate beneficial in essential tremor?. Nat Rev Neurol 2, 478–479 (2006). https://doi.org/10.1038/ncpneuro0266
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ncpneuro0266